| Application no. and date | 00968595.9 (espacenet) (Federated) (European Patent Register), 20001002 | | Patent/reg. no. and date | DK/EP 1224195, 20050518 | | Publication date | 20020724 | | Priority no. and date | US 158773 P, 19991012, US 194615 P, 20000405 | | EP pub. no. and date |
EP 1224195 20020724 | | Effective date | | | Applicant/owner | AstraZeneca AB, SE-151 85 Södertälje, SE | | Applicant ref. no. | 121097 | | Inventor | ELLSWORTH, Bruce, 7 Glenview Drive
Princeton, NJ 08540, US,
SHER, Philip, M., 18 Mifflin Court
Plainsboro, NJ 08536, US,
WU, Gang, 390 Rosedale Road
Princeton, NJ 08540, US,
WASHBURN, William, N., 120 Pleasant Valley Road
Titusville, NJ 08560, US,
MENG, Wei, 404 Bollen Court
Pennington, NJ 08534, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/70 (2006.01) , A61P 3/10 (2006.01) , C07H 15/203 (2006.01) | | Title | C-Aryl-glucosid-SGLT2-inhibitorer | | Int. application no. | US2000027187 | | Int. publication no. | WO2001027128 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
